Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside.
Mezentsev A, Bezsonov E, Kashirskikh D, Baig MS, Eid AH, Orekhov A.
Publications
Publications Link :
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk.
Dabravolski SA, Bezsonov EE, Baig MS, Popkova TV, Nedosugova LV, Starodubova AV, Orekhov AN
Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein.
Alagumuthu M, Rajpoot S, Baig MS.
Dual targeting of 3CL(pro) and PL(pro) of SARS-CoV-2: A novel structure-based design approach to treat COVID-19.
Rajpoot S, Alagumuthu M, Baig MS.
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.
Baig MS, Alagumuthu M, Rajpoot S, Saqib U.
Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced insulin-like growth factor-1 secretion by prostate stromal cells.
Ohishi T, Abe H, Sakashita C, Saqib U, Baig MS, Ohba SI, Inoue H, Watanabe T, Shibasaki M, Kawada M.
Macrophage neuronal nitric oxide synthase (NOS1) controls the inflammatory response and foam cell formation in atherosclerosis.
Roy A, Saqib U, Wary K, Baig MS.
Tumor-derived exosomes in the regulation of macrophage polarization.
Baig MS, Roy A, Rajpoot S, Liu D, Savai R, Banerjee S, Kawada M, Faisal SM, Saluja R, Saqib U, Ohishi T, Wary KK.
Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway.
Naim A, Baig MS
NOS1-derived nitric oxide facilitates macrophage uptake of low-density lipoprotein.
Roy A, Banerjee S, Saqib U, Baig MS.
Inhibition of the TIRAP-c-Jun interaction as a therapeutic strategy for AP1-mediated inflammatory responses.
Srivastava M, Saqib U, Banerjee S, Wary K, Kizil B, Muthu K, Baig MS.
Scaffolding role of TcpB in disrupting TLR4-Mal interactions: Three to tango.
Saqib U, Baig MS.
Drug repositioning as an effective therapy for protease-activated receptor 2 inhibition.
Saqib U, Savai R, Liu D, Banerjee S, Baig MS.
Structural insights of resveratrol with its binding partners in the toll-like receptor 4 pathway.
Saqib U, Faisal SM, Saluja R, Baig MS.
Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets.
Saqib U, Kelley TT, Panguluri SK, Liu D, Savai R, Baig MS, Schürer SC.